Correlation analysis on combined medication with of Xiyanping injection in treatment of lung infection in real world.
- Author:
Xiu-ping YIN
;
Yan-ming XIE
;
Ying-jie ZHI
;
Wei YANG
;
Zhi-fei WANG
;
Jian HUO
- Publication Type:Journal Article
- MeSH:
Adult;
Anti-Bacterial Agents;
administration & dosage;
Ascorbic Acid;
administration & dosage;
Cephamycins;
administration & dosage;
Drug Therapy, Combination;
Drugs, Chinese Herbal;
administration & dosage;
Female;
Hospital Information Systems;
Humans;
Lung Diseases;
drug therapy;
Male;
Middle Aged;
Young Adult
- From:
China Journal of Chinese Materia Medica
2015;40(12):2440-2444
- CountryChina
- Language:Chinese
-
Abstract:
To analyze the regularity in combined medication with Xiyanping injection (Xiyanping for short) in the real world by as- sociation rules. Totally 5 822 patients using Xiyanping injection was collected from the 18 Class III Grade I hospitals nationwide to study the combined medication information of the patient with lung infection and make the analysis by using association rules and Apriori. According to the results, major drugs combined with Xiyanping in treatment of lung infection included compound amino acid, inosine, coenzyme A, cytidine triphosphate, vitamin C. Common drugs combined with Xiyanping can be divided into 5 categories: nutrition support therapy (vitamin C, compound amino acid) , coenzymes (coenzyme A, cytidine triphosphate, inosine), expectorants and antiasthmatics (ambroxol, salbutamol, doxofylline), hormones (dexamethasone, budesonide), antibiotics (mainly cefminox). The main combined medicines mostly conformed to the regularity for drugs treating lung infection. In addition, there were two most common medical combination models: the model for Xiyanping combined a single medicine is Xiyanping + nutrition support therapy, while the model for Xiyanping combined two or more than two medicines is Xiyanping + nutrition support therapy + coenzyme. Pharmacologically, Xiyanping is mostly combined with western medicines with similar pharmacological effects to substitute or supplement the antibiotic effect in treating lung infection. However, further studies shall be conducted for the safety and rationality of the combined medication based on clinical practices, in order to provide reference for clinical medication.
